Shin Nippon Biomedical Laboratories, Ltd.'s total assets for Q3 2024 were ¥97.30B, an increase of 9.34% from the previous quarter. JP:2395 total liabilities were ¥52.21B for the fiscal quarter, a -0.62% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Total Assets
¥ 92.42B
¥ 76.30B
¥ 57.24B
¥ 39.31B
¥ 36.97B
Total Liabilities
¥ 52.33B
¥ 42.14B
¥ 30.88B
¥ 19.59B
¥ 21.13B
Total Equity Gross Minority
¥ 40.09B
¥ 34.16B
¥ 26.36B
¥ 19.72B
¥ 15.84B
Other Metrics
Currency in JPY
Shin Nippon Biomedical Laboratories, Ltd. Debt to Assets